Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 5
2006 1
2007 5
2008 6
2009 6
2010 8
2011 4
2012 6
2013 4
2014 4
2015 2
2018 4
2019 2
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Gentilini OD, et al. JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759. JAMA Oncol. 2023. PMID: 37733364 Free PMC article.
Letrozole.
Dellapasqua S, Colleoni M. Dellapasqua S, et al. Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):251-9. doi: 10.1517/17425250903540246. Expert Opin Drug Metab Toxicol. 2010. PMID: 20095792 Review.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Why did the study fail?
Dellapasqua S, Castiglione-Gertsch M. Dellapasqua S, et al. Eur J Cancer. 2005 Dec;41(18):2784-6. doi: 10.1016/j.ejca.2005.08.024. Epub 2005 Oct 25. Eur J Cancer. 2005. PMID: 16253501 No abstract available.
Metronomic therapy and breast cancer: a systematic review.
Montagna E, Cancello G, Dellapasqua S, Munzone E, Colleoni M. Montagna E, et al. Among authors: dellapasqua s. Cancer Treat Rev. 2014 Sep;40(8):942-50. doi: 10.1016/j.ctrv.2014.06.002. Epub 2014 Jun 18. Cancer Treat Rev. 2014. PMID: 24998489 Review.
The TNM classification of breast cancer: need for change.
Arnone P, Zurrida S, Viale G, Dellapasqua S, Montagna E, Arnaboldi P, Intra M, Veronesi U. Arnone P, et al. Among authors: dellapasqua s. Updates Surg. 2010 Oct;62(2):75-81. doi: 10.1007/s13304-010-0014-y. Updates Surg. 2010. PMID: 20845013 No abstract available.
Investigations after adjuvant therapy.
Dellapasqua S. Dellapasqua S. Cancer Treat Res. 2009;151:331-52. doi: 10.1007/978-0-387-75115-3_21. Cancer Treat Res. 2009. PMID: 19593522 Review. No abstract available.
Adjuvant therapies for special types of breast cancer.
Colleoni M, Russo L, Dellapasqua S. Colleoni M, et al. Among authors: dellapasqua s. Breast. 2011 Oct;20 Suppl 3:S153-7. doi: 10.1016/S0960-9776(11)70315-0. Breast. 2011. PMID: 22015285 Free article. Review.
59 results